Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New treatment tested for severe asthma and nasal polyps

NCT ID NCT05575037

Summary

This study is testing whether the medication dupilumab can help people with aspirin-exacerbated respiratory disease, a condition that causes severe asthma, nasal polyps, and loss of smell. Seventeen participants will receive four doses of the medication over eight weeks. Researchers will measure changes in nasal polyps, breathing, sense of smell, and quality of life to see if the treatment is effective.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

Conditions

Explore the condition pages connected to this study.